Research Archive — Page 52 of 134
-
September 27, 2022
Diagnostic biomarker for bone disorder
A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated. -
September 26, 2022
Gender differences with bladder pain
Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report. -
September 22, 2022
Nominations sought for Research Staff Awards
Nominations for the 2022 Vanderbilt University School of Medicine Research Staff Awards are now being accepted. -
September 22, 2022
Reduced exercise capacity in ICU survivors
ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose. -
September 22, 2022
Nerve cells and cancer progression
Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression. -
September 15, 2022
Study suggests new mechanism for lipid transporter
A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought. -
September 13, 2022
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.